• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Child’s vaccination data handily available via Kasvuseula service

Bioengineer by Bioengineer
February 23, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Parents can now follow their tots' vaccinations via the Kasvuseula online service, which provides analytical data on the child's growth. Developed by VTT Technical Research Centre of Finland, this new service feature is based on reliable data – maintained by the Pharmaceutical Information Centre- on children's vaccinations. Kasvuseula.fi is a user-friendly, online service that provides parents with reliable, analysed data on the growth of their child and any abnormalities. A new vaccination data section has now been added to the service.

The service provides parents with a handy way of recording their children's vaccinations and monitoring the progress of the recommended vaccination programme. Vaccination data is visualised by a clear diagram showing vaccinations under the national vaccination programme and an indicative vaccination schedule. In this way, Kasvuseula serves as a tool which supports and complements Finnish health care.

"With this service, VTT wants to help parents to monitor the growth and development of their children. Users have warmly welcomed the growth data section; I think that providing vaccination data at the same address makes the service even more useful and user friendly," says Kari Kohtamäki, Key Account Manager, who adds that data on over 23,000 children has been added to the service.

"Due to the online information overload on vaccines, we warmly welcomed VTT's proposal to engage in cooperation. Kasvuseula is a natural place from which to provide parents with easily understandable and reliable information on vaccines and vaccinations. From there, users can easily access the Rokotustieto.fi service for more details on the issue," says Topi Hanhela, Director, Customer Relations & Business Development of the Pharmaceutical Information Centre.

###

VTT wants to lead the way towards the health care of the future by creating new, digital health services.

Kasvuseula: https://kasvuseula.fi/

Watch the video: https://www.youtube.com/watch?v=G_CCF96yFGQ

Further details:

VTT
Kari Kohtamäki, Key Account Manager
Tel. +358 40 512 7611
[email protected]

Pharmaceutical Information Centre

Topi Hanhela, Director, Customer Relations & Business Development
Tel. +358 40 518 0792
[email protected]

Further information on VTT:

Olli Ernvall
Senior Vice President, Communications
358 20 722 6747
[email protected]
http://www.vtt.fi

VTT Technical Research Centre of Finland Ltd is the leading research and technology company in the Nordic countries. We use our research and knowledge to provide expert services for our domestic and international customers and partners, and for both private and public sectors. We use 4,000,000 hours of brainpower a year to develop new technological solutions. VTT in social media: Twitter @VTTFinland, Facebook, LinkedIn, YouTube, Instagram and Periscope.

Media Contact

Kari Kohtamäki
[email protected]
358-405-127-611
@VTTFinland

http://www.vtt.fi/?lang=en

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

ERβ Provides Gender-Specific Defense Against Alzheimer’s Disease

ERβ Provides Gender-Specific Defense Against Alzheimer’s Disease

October 12, 2025

Microfluidic Gradients Form Stem Cell CNS Model

October 12, 2025

Evolution of Primary Autoimmune Neuropathies Explained

October 12, 2025

Starting Heart Disease Prevention in Childhood

October 12, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1221 shares
    Share 488 Tweet 305
  • New Study Reveals the Science Behind Exercise and Weight Loss

    103 shares
    Share 41 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    100 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    89 shares
    Share 36 Tweet 22

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

ERβ Provides Gender-Specific Defense Against Alzheimer’s Disease

Microfluidic Gradients Form Stem Cell CNS Model

Evolution of Primary Autoimmune Neuropathies Explained

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 64 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.